Blog
Belantamab: A Game-Changer in Multiple Myeloma Therapy
Belantamab mafodotin is an antibody-drug conjugate (ADC) targeting B-cell maturation antigen (BCMA), a protein highly expressed on malignant plasma cells in multiple myeloma (MM). By deli
…
13th Jan 2025